FDA inspection

Nikolaos T. Pyrsopoulos, M.D.: FDA inspection ending Feb 22, 2022

FDA inspection 1163021 · Voluntary Action Indicated (VAI) · Newark, NJ

Key facts

Inspection ID 1163021
Firm Nikolaos T. Pyrsopoulos, M.D.
FEI number 3021021319
Address 90 Bergen St Fl 2 Ste 2100
City Newark
State NJ
ZIP 07103
Country United States
Fiscal year 2022
Inspection end date Feb 22, 2022
Classification Voluntary Action Indicated (VAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections